MBRX Chart
- 52-Week Range: $1.19 - $3.95
- Market Capitalization: $39.36M
- Short Percentage: 0%
- Target Price: $12.39
- Shares Outstanding: 28.58M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MBRX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Moleculin Biotech Annamycin Doublet Therapy Shows 68% Overall Survival In Animal StudyBenzinga | February 14th
- Moleculin Biotech, Inc. to Present at the Virtual Investor 2022 Top Picks ConferencePRNewsWire | January 20th
- Moleculin Biotech, Inc to Present at the Virtual Investor Roundtable EventPRNewsWire | November 12th
- Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs UpdatePRNewsWire | November 11th
- Moleculin to Present at the 2021 Cantor Virtual Global Healthcare ConferencePRNewsWire | September 27th
- Moleculin to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech SummitPRNewsWire | September 17th
Company Info
Website: https://www.moleculin.com
Address: 5300 Memorial Drive, Houston, TX, United States, 77007
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
Address: 5300 Memorial Drive, Houston, TX, United States, 77007
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
$MBRX eyeing for a scalp
$MBRX what’s next bulls
$MBRX rubbish
$MBRX what’s gonna happen now
$MBRX we back boys
$MBRX Spike it!
$MBRX I love this stonk!
$MBRX what a horse shit show!
$MBRX HODLing
and buying more when I can.
$MBRX to the moon